首頁 > 市場調查報告書 > 醫療設備

體外診斷癌症癌症診斷

市場調查報告書

商品編碼

1820203

子宮頸癌診斷市場報告，按檢測類型（巴氏抹片檢查、HPV 檢測、子宮頸活體組織切片、陰道鏡檢查等）、年齡層（20 至 35 歲、35 歲以上）和地區分類，2025 年至 2033 年

Cervical Cancer Diagnostics Market Report by Test Type (Pap Testing, HPV Testing, Cervical Biopsies, Colposcopy, and Others), Age Group (20 to 35 Years, Above 35 Years), and Region 2025-2033

出版日期: 2025年09月01日 | 出版商:

IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

2024年全球子宮頸癌診斷市場規模達83億美元。展望未來， IMARC Group預計到2033年市場規模將達到127億美元，2025-2033年期間的成長率（CAGR）為4.56%。

子宮頸癌診斷依賴一系列先進的實驗室檢測、工具和程序來評估人類乳突病毒 (HPV) 的異常細胞或病毒株。診斷過程包括：取子宮頸錐切術、穿刺切片、子宮頸管刮除術及電熱環套紮術等組織樣本，在陰道鏡檢查期間進行子宮頸的全面檢查。檢查結束後，也會進行血液檢查、胸部 X 光檢查、全身電腦斷層掃描 (CT)、磁振造影 (MRI)、正子斷層掃描 (PET) 以及膀胱和直腸的目視檢查，以確定疾病分期。

被診斷患有梅毒、披衣菌、淋病和後天免疫缺乏症候群（HIV/AIDS）等性傳染感染 (STI) 的人數大幅增加，導致全球 HPV 感染風險不斷上升。此外，吸菸者人數不斷增加也增加了罹患子宮頸癌的風險，這些因素共同構成了推動市場成長的關鍵因素之一。此外，人們對早期診斷認知的不斷提高，也促使人們開始使用能夠快速且準確地檢測結果的 HPV 家用檢測試劑盒。優惠的報銷政策也支持了市場的成長。此外，人們對個人化治療方案的偏好日益成長，也推動了子宮頸癌診斷的需求。此外，包括手術、放射療法、化療、錐形活體組織切片、免疫療法和子宮頸切除術在內的一系列其他治療方案的出現，也促進了市場的成長。此外，對開發低成本高效檢測產品的日益重視預計將推動市場的成長。

本報告回答的關鍵問題

全球子宮頸癌診斷市場有多大？ 2025-2033年全球子宮頸癌診斷市場的預期成長率是多少？
推動全球子宮頸癌診斷市場發展的關鍵因素有哪些？
COVID-19 對全球子宮頸癌診斷市場有何影響？
根據檢測類型，全球子宮頸癌診斷市場是如何分佈的？
全球子宮頸癌診斷市場的主要地區有哪些？
全球子宮頸癌診斷市場的主要參與者/公司有哪些？

Cervical cancer diagnostics rely on a series of advanced laboratory tests, tools and procedures to evaluate abnormal cells or strains of the human papillomavirus (HPV). They are performed by taking a sample of the tissue obtained through conization, punch biopsy, endocervical curettage and the electrical wire loop for a thorough examination of the cervix during colposcopy. After detection, tests like blood, chest X-ray, body computed tomography (CT) scan, magnetic resonance imaging (MRI), positron emission tomography (PET) scan and visual examination of bladder and rectum are conducted to determine the disease stage.

A considerable rise in the number of individuals diagnosed with sexually transmitted infections (STIs), such as syphilis, chlamydia, gonorrhea and acquired immune deficiency syndrome (HIV/AIDS), is escalating the risk of HPV infection worldwide. This, along with the growing number of smokers, which increases the chances of developing cervical cancer, represents one of the key factors bolstering the market growth. Furthermore, the rising awareness about early diagnosis is encouraging the adoption of HPV home testing kits that provide quick and accurate test results. The presence of favorable reimbursement policies also supports the market growth. Apart from this, rising preferences for personalized treatment plans are escalating the demand for cervical cancer diagnostics. Additionally, the availability of a range of other treatment options, including surgery, radiation therapy, chemotherapy, cone biopsy, immunotherapy and trachelectomy, is contributing to the market growth. Moreover, the growing emphasis on developing low-cost and efficient testing products is anticipated to fuel the market growth.

Key Market Segmentation:

Breakup by Test Type:

Pap Testing
HPV Testing
Cervical Biopsies
Colposcopy
Others

Breakup by Age Group:

20 to 35 years
Above 35 years

Breakup by Region:

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
Latin America
- Brazil
- Mexico
- Others
Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Arbor Vita Corporation, Becton, Dickinson and Company, Cooper Surgical Inc., F. Hoffmann-La Roche AG, Guided Therapeutics Inc., Hologic Inc., Qiagen, Quest Diagnostics Incorporated and Siemens Healthcare GmbH.

Key Questions Answered in This Report

1.How big is the global cervical cancer diagnostics market?
2.What is the expected growth rate of the global cervical cancer diagnostics market during 2025-2033?
3.What are the key factors driving the global cervical cancer diagnostics market?
4.What has been the impact of COVID-19 on the global cervical cancer diagnostics market?
5.What is the breakup of the global cervical cancer diagnostics market based on the test type?
6.What are the key regions in the global cervical cancer diagnostics market?
7.Who are the key players/companies in the global cervical cancer diagnostics market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview
4.2 Key Industry Trends

5 Global Cervical Cancer Diagnostics Market

5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Test Type

6.1 Pap Testing
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
6.2 HPV Testing
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
6.3 Cervical Biopsies
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
6.4 Colposcopy
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
6.5 Others
- 6.5.1 Market Trends
- 6.5.2 Market Forecast

7 Market Breakup by Age Group

7.1 20 to 35 years
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
7.2 Above 35 years
- 7.2.1 Market Trends
- 7.2.2 Market Forecast

8 Market Breakup by Region

8.1 North America
- 8.1.1 United States
  - 8.1.1.1 Market Trends
  - 8.1.1.2 Market Forecast
- 8.1.2 Canada
  - 8.1.2.1 Market Trends
  - 8.1.2.2 Market Forecast
8.2 Asia-Pacific
- 8.2.1 China
  - 8.2.1.1 Market Trends
  - 8.2.1.2 Market Forecast
- 8.2.2 Japan
  - 8.2.2.1 Market Trends
  - 8.2.2.2 Market Forecast
- 8.2.3 India
  - 8.2.3.1 Market Trends
  - 8.2.3.2 Market Forecast
- 8.2.4 South Korea
  - 8.2.4.1 Market Trends
  - 8.2.4.2 Market Forecast
- 8.2.5 Australia
  - 8.2.5.1 Market Trends
  - 8.2.5.2 Market Forecast
- 8.2.6 Indonesia
  - 8.2.6.1 Market Trends
  - 8.2.6.2 Market Forecast
- 8.2.7 Others
  - 8.2.7.1 Market Trends
  - 8.2.7.2 Market Forecast
8.3 Europe
- 8.3.1 Germany
  - 8.3.1.1 Market Trends
  - 8.3.1.2 Market Forecast
- 8.3.2 France
  - 8.3.2.1 Market Trends
  - 8.3.2.2 Market Forecast
- 8.3.3 United Kingdom
  - 8.3.3.1 Market Trends
  - 8.3.3.2 Market Forecast
- 8.3.4 Italy
  - 8.3.4.1 Market Trends
  - 8.3.4.2 Market Forecast
- 8.3.5 Spain
  - 8.3.5.1 Market Trends
  - 8.3.5.2 Market Forecast
- 8.3.6 Russia
  - 8.3.6.1 Market Trends
  - 8.3.6.2 Market Forecast
- 8.3.7 Others
  - 8.3.7.1 Market Trends
  - 8.3.7.2 Market Forecast
8.4 Latin America
- 8.4.1 Brazil
  - 8.4.1.1 Market Trends
  - 8.4.1.2 Market Forecast
- 8.4.2 Mexico
  - 8.4.2.1 Market Trends
  - 8.4.2.2 Market Forecast
- 8.4.3 Others
  - 8.4.3.1 Market Trends
  - 8.4.3.2 Market Forecast
8.5 Middle East and Africa
- 8.5.1 Market Trends
- 8.5.2 Market Breakup by Country
- 8.5.3 Market Forecast

9 SWOT Analysis

9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats

10 Value Chain Analysis

11 Porters Five Forces Analysis

11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

13.1 Market Structure
13.2 Key Players
13.3 Profiles of Key Players
- 13.3.1 Abbott Laboratories
  - 13.3.1.1 Company Overview
  - 13.3.1.2 Product Portfolio
  - 13.3.1.3 Financials
  - 13.3.1.4 SWOT Analysis
- 13.3.2 Arbor Vita Corporation
  - 13.3.2.1 Company Overview
  - 13.3.2.2 Product Portfolio
- 13.3.3 Becton, Dickinson and Company
  - 13.3.3.1 Company Overview
  - 13.3.3.2 Product Portfolio
  - 13.3.3.3 Financials
  - 13.3.3.4 SWOT Analysis
- 13.3.4 Cooper Surgical Inc.
  - 13.3.4.1 Company Overview
  - 13.3.4.2 Product Portfolio
- 13.3.5 F. Hoffmann-La Roche AG
  - 13.3.5.1 Company Overview
  - 13.3.5.2 Product Portfolio
  - 13.3.5.3 Financials
- 13.3.6 Guided Therapeutics Inc.
  - 13.3.6.1 Company Overview
  - 13.3.6.2 Product Portfolio
  - 13.3.6.3 SWOT Analysis
- 13.3.7 Hologic Inc.
  - 13.3.7.1 Company Overview
  - 13.3.7.2 Product Portfolio
  - 13.3.7.3 Financials
  - 13.3.7.4 SWOT Analysis
- 13.3.8 Qiagen
  - 13.3.8.1 Company Overview
  - 13.3.8.2 Product Portfolio
  - 13.3.8.3 Financials
  - 13.3.8.4 SWOT Analysis
- 13.3.9 Quest Diagnostics Incorporated
  - 13.3.9.1 Company Overview
  - 13.3.9.2 Product Portfolio
  - 13.3.9.3 Financials
  - 13.3.9.4 SWOT Analysis
- 13.3.10 Siemens Healthcare GmbH
  - 13.3.10.1 Company Overview
  - 13.3.10.2 Product Portfolio
  - 13.3.10.3 SWOT Analysis

簡介目錄圖表

List of Figures

Figure 1: Global: Cervical Cancer Diagnostics Market: Major Drivers and Challenges
Figure 2: Global: Cervical Cancer Diagnostics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Cervical Cancer Diagnostics Market: Breakup by Test Type (in %), 2024
Figure 5: Global: Cervical Cancer Diagnostics Market: Breakup by Age Group (in %), 2024
Figure 6: Global: Cervical Cancer Diagnostics Market: Breakup by Region (in %), 2024
Figure 7: Global: Cervical Cancer Diagnostics (Pap Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 8: Global: Cervical Cancer Diagnostics (Pap Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 9: Global: Cervical Cancer Diagnostics (HPV Testing) Market: Sales Value (in Million USD), 2019 & 2024
Figure 10: Global: Cervical Cancer Diagnostics (HPV Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 11: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market: Sales Value (in Million USD), 2019 & 2024
Figure 12: Global: Cervical Cancer Diagnostics (Cervical Biopsies) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 13: Global: Cervical Cancer Diagnostics (Colposcopy) Market: Sales Value (in Million USD), 2019 & 2024
Figure 14: Global: Cervical Cancer Diagnostics (Colposcopy) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 15: Global: Cervical Cancer Diagnostics (Others) Market: Sales Value (in Million USD), 2019 & 2024
Figure 16: Global: Cervical Cancer Diagnostics (Others) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 17: Global: Cervical Cancer Diagnostics (20 to 35 years) Market: Sales Value (in Million USD), 2019 & 2024
Figure 18: Global: Cervical Cancer Diagnostics (20 to 35 years) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 19: Global: Cervical Cancer Diagnostics (Above 35 years) Market: Sales Value (in Million USD), 2019 & 2024
Figure 20: Global: Cervical Cancer Diagnostics (Above 35 years) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 21: North America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 22: North America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 23: United States: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 24: United States: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 25: Canada: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 26: Canada: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 27: Asia-Pacific: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 28: Asia-Pacific: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 29: China: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 30: China: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 31: Japan: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 32: Japan: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 33: India: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 34: India: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 35: South Korea: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 36: South Korea: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 37: Australia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 38: Australia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 39: Indonesia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 40: Indonesia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 41: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 42: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 43: Europe: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 44: Europe: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 45: Germany: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 46: Germany: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 47: France: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 48: France: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 49: United Kingdom: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 50: United Kingdom: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 51: Italy: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 52: Italy: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 53: Spain: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 54: Spain: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 55: Russia: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 56: Russia: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 57: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 58: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 59: Latin America: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 60: Latin America: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 61: Brazil: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 62: Brazil: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 63: Mexico: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 64: Mexico: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 65: Others: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 66: Others: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 67: Middle East and Africa: Cervical Cancer Diagnostics Market: Sales Value (in Million USD), 2019 & 2024
Figure 68: Middle East and Africa: Cervical Cancer Diagnostics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 69: Middle East and Africa: Cervical Cancer Diagnostics Market: Breakup by Country (in %), 2024
Figure 70: Global: Cervical Cancer Diagnostics Industry: SWOT Analysis
Figure 71: Global: Cervical Cancer Diagnostics Industry: Value Chain Analysis
Figure 72: Global: Cervical Cancer Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Cervical Cancer Diagnostics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
Table 3: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Age Group (in Million USD), 2025-2033
Table 4: Global: Cervical Cancer Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 5: Global: Cervical Cancer Diagnostics Market: Competitive Structure
Table 6: Global: Cervical Cancer Diagnostics Market: Key Players

02-2729-4219

+886-2-2729-4219